Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    NIAID | Recruiting | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Condition: Liver Transplantation
Interventions: Biological: Anti-Thymocyte Globulin - Rabbit;   Biological: darTreg Infusion;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Anti-Infective Prophylaxis;   Procedure: Leukapheresis;   Procedure: Blood draws;   Procedure: Liver biopsies;   Procedure: Liver transplantation
22 Recruiting Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
Condition: Asthma
Intervention: Biological: Segmental airway allergen challenge
23 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
Intervention:
24 Recruiting Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Conditions: Heart Transplant;   Small Intestine Transplant;   Kidney Transplant;   Liver Transplant;   Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder;   PTLDs
Interventions: Procedure: transplant;   Drug: Immunosuppressive Drugs
25 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
26 Recruiting Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Conditions: Kidney Transplant;   Adult Living Donor Kidney Transplant Recipients;   Renal Transplant;   Living Kidney Donor
Interventions: Biological: Polyclonal Regulatory T Cells;   Biological: Donor-Alloantigen-Reactive Regulatory T Cells;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Procedure: Biopsy, Kidney;   Procedure: Blood Draw;   Procedure: Leukapheresis;   Procedure: IS regimen conversion
27 Recruiting CLAD Phenotype Specific Risk Factors and Mechanisms.
Condition: Lung Transplant
Interventions: Procedure: Blood Draw;   Procedure: Bronchoscopy
28 Recruiting Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
Condition: Asthma
Interventions: Drug: omalizumab;   Biological: Rhinovirus (strain 16)
29 Recruiting A Cohort Study of Operationally Tolerant Allograft Recipients
Conditions: Kidney Transplant;   Liver Transplant
Intervention: Procedure: Blood Draw
30 Recruiting School Inner-City Asthma Intervention Study (SICAS-2)
Condition: Asthma
Interventions: Other: integrated pest management;   Other: air purifier;   Other: No intervention (control)
31 Recruiting Molecular Basis of Food Allergy
Conditions: Food Allergy;   Eosinophilic Esophagitis
Intervention:
32 Recruiting Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Allergic Asthma
Condition: Allergic Asthma
Interventions: Device: CREON2000A;   Device: Sham
33 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Post BMT
Intervention:
34 Recruiting Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Hematopoietic and Lymphoid Cell Neoplasm;   HIV Infection
Interventions: Other: Laboratory Biomarker Analysis;   Procedure: Leukapheresis
35 Recruiting Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis
Conditions: Systemic Scleroderma;   Severe Systemic Sclerosis
Interventions: Drug: fludarabine phosphate;   Drug: Mycophenolic Acid;   Drug: tacrolimus;   Radiation: total-body irradiation;   Procedure: bone marrow transplantation;   Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Other: flow cytometry;   Procedure: biopsy;   Drug: cyclophosphamide
36 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
37 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
38 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Condition: Atopic Dermatitis
Intervention:
39 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
40 Recruiting IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
Condition: HIV Infection
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.